{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:31:21Z","timestamp":1791876681052,"version":"4.3.4"},"reference-count":84,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Muscle and Nerve"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disorder with complex biology and significant clinical heterogeneity. Many preclinical and early phase ALS clinical trials have yielded promising results that could not be replicated in larger phase 3 confirmatory trials. One reason for the lack of reproducibility may be ALS biological and clinical heterogeneity. Therefore, in this review, we explore sources of ALS heterogeneity that may reduce statistical power to evaluate efficacy in ALS trials. We also review efforts to manage clinical heterogeneity, including use of validated disease outcome measures, predictive biomarkers of disease progression, and individual clinical risk stratification. We propose that personalized prognostic models with use of predictive biomarkers may identify patients with ALS for whom a specific therapeutic strategy may be expected to be more successful. Finally, the rapid application of emerging clinical and biomarker strategies may reduce heterogeneity, increase trial efficiency, and, in turn, accelerate ALS drug development.<\/jats:p>","DOI":"10.1002\/mus.26801","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T11:26:41Z","timestamp":1578050801000},"page":"156-166","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS"],"prefix":"10.1002","volume":"62","author":[{"given":"Namita A.","family":"Goyal","sequence":"first","affiliation":[{"name":"University of California Irvine California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Berry","sequence":"additional","affiliation":[{"name":"Healey Center at Massachusetts General Hospital Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Windebank","sequence":"additional","affiliation":[{"name":"Mayo Clinic Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan P.","family":"Staff","sequence":"additional","affiliation":[{"name":"Mayo Clinic Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Maragakis","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard H.","family":"van den Berg","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Genge","sequence":"additional","affiliation":[{"name":"Montreal Neurological Institute and Hospital Montreal, Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Miller","sequence":"additional","affiliation":[{"name":"California Pacific Medical Center San Francisco California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Baloh","sequence":"additional","affiliation":[{"name":"Robert H. Baloh, Cedars\u2010Sinai Medical Center California Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Kern","sequence":"additional","affiliation":[{"name":"Brainstorm Cell Therapeutics New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Gothelf","sequence":"additional","affiliation":[{"name":"Brainstorm Cell Therapeutics New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Lebovits","sequence":"additional","affiliation":[{"name":"Brainstorm Cell Therapeutics New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merit","family":"Cudkowicz","sequence":"additional","affiliation":[{"name":"Healey Center at Massachusetts General Hospital Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30089-9"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024125"},{"key":"e_1_2_12_4_1","article-title":"A systematic review of enrichment strategies for current clinical trials. In: Proceedings from the ALS 29th International Symposium on ALS\/MND; December 7\u20109, 2018; Glasgow","author":"Goyal NA","journal-title":"United Kingdom."},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature20413"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav9776"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3622"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01063"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410410212"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.02.027"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00400"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.12.016"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000729"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000951"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2014.990036"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2017.1418001"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20120119"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.1"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001447.pub3"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30054-1"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2012.762930"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007242"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S153196"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1530987"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2018-0149"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1091-7"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2017.03.027"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00731"},{"key":"e_1_2_12_29_1","article-title":"MicroRNA changes in the NurOwn phase 2 ALS randomized trial: relationship to neuroprotection and innate immunity. Presented at: The 17th Annual Northeast ALS Consortium Meeting; October 2\u20104, 2018; Clearwater Beach","author":"Berry J","journal-title":"Florida."},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.4321"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00186"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40632-4"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.348"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26042"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3051"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fninf.2018.00036"},{"key":"e_1_2_12_37_1","article-title":"Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials","author":"Eijk RPA","journal-title":"Neurology."},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.550"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/biom.12461"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105313442202"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2014.959024"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2017.1361442"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30115-1"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000100"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2018.1426770"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0341-2"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.6179"},{"key":"e_1_2_12_48_1","article-title":"Modulation of CSF miRNAs in ALS phase 2 study participants treated with MSC\u2010NTF (NurOwn). Presented at: 70th Annual Meeting of the American Academy of Neurology; April 21\u201027, 2018; Los Angeles","author":"Aricha R","journal-title":"California."},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1096"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008620"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2015.07.019"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314661"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(99)00210-5"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000148648.38313.64"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000194316.91908.8a"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.3109\/17482960903093710"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002251"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.072660"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.3339"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.03403"},{"key":"e_1_2_12_61_1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.0000000000002941","article-title":"Quantitative strength testing in ALS clinical trials","volume":"87","author":"Shefner JM","year":"2016","journal-title":"Neurology."},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22253"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.3109\/17482968.2012.688837"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn071"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-016-0487-6"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/17549507.2018.1508499"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0672-6"},{"key":"e_1_2_12_68_1","first-page":"123","article-title":"A review of cervical spine MRI in ALS patients","volume":"11","author":"Antonescu F","year":"2018","journal-title":"J Med Life."},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2014.943672"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2016.1214733"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087398"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003741"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001642"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-307672"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2016.1241279"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-317138"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201201544"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0424-x"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71601"},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-313521"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1880-5"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-1-42"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044789"},{"key":"e_1_2_12_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.08.012"},{"key":"e_1_2_12_85_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00578"}],"container-title":["Muscle &amp; Nerve"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmus.26801","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mus.26801","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/mus.26801","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mus.26801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T13:56:15Z","timestamp":1722261375000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mus.26801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1002\/mus.26801"],"URL":"https:\/\/doi.org\/10.1002\/mus.26801","archive":["Portico"],"relation":{},"ISSN":["0148-639X","1097-4598"],"issn-type":[{"value":"0148-639X","type":"print"},{"value":"1097-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"2019-08-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}